Notice Regarding Cyber Attack…for more information click here
a A Proud to be a Banner Health Center of Excellence

Our Leadership

Eric Reiman

Eric M. Reiman, MD

Titles

Dr. Reiman is Executive Director of the Banner Alzheimer’s Institute and Chief Executive Officer for Banner Research, the umbrella organization for research at one of the nation’s largest non-profit health systems. He is also Professor of Psychiatry at the University of Arizona, University Professor of Neuroscience at Arizona State University, Clinical Director of Neurogenomics at the Translational Genomics Research Institute (TGen), and Director of the Arizona Alzheimer’s Consortium.

Medical education

Dr. Reiman earned his undergraduate and medical degrees at Duke University in Durham, North Carolina.

Residencies

Dr. Reiman received his Psychiatry Residency Training at Duke University and Washington University in St. Louis. He launched his career in brain imaging research at Washington University. 

Board certification

Dr. Reiman is board certified in Psychiatry.

Areas of specialization

Dr. Reiman and his colleagues have made pioneering contributions in brain imaging research, the study of human behaviors, the earliest detection and tracking of Alzheimer’s disease in persons at different levels of genetic risk, and the accelerated evaluation of Alzheimer’s prevention therapies. He is an author of more than 300 publications, a principal investigator of six active National Institutes of Health grants, and recipient of the Potamkin Prize for his contributions to Alzheimer's Disease research. 

Professional highlights

Under Dr. Reiman’s leadership, researchers and institutional leaders in the state established the Arizona Alzheimer’s Consortium, the leading model of statewide collaboration in AD research. Researchers in the Consortium have capitalized on complementary strengths and shared resources from Arizona’s leading research organizations, generated several thousand research publications and more than $1 billion in grants, contracts and other investments, and made major contributions to the study of Alzheimer’s disease, related disorders, and the aging brain.

With the recently established partnership between Banner Health and the University of Arizona, he and his colleagues hope to help advance the science of health care delivery, leverage unusually large data sets and initiatives, including that in the nation’s Precision Medicine Initiative, and capitalize on changes in the emerging health care financing system. In another important relationship, he and his colleagues have also begun to establish the Arizona State University-Banner Neurodegenerative Disease Research Center, an exceptionally large basic and translational research program in the fight against Alzheimer’s, Parkinson’s and other neurodegenerative diseases.

In 2006, Dr. Reiman and his colleagues established Banner Alzheimer’s Institute in order to help accelerate the evaluation of Alzheimer’s prevention therapies, establish a new standard of comprehensive dementia care for patients and family caregivers, and forge new models of collaboration in biomedical research.

Dr. Reiman, Pierre Tariot, MD, and their colleagues established the Alzheimer’s Prevention Initiative (API) to launch a new era in Alzheimer’s prevention research, establish the scientific means, accelerated approval pathway, and shared enrollment resources to rapidly evaluate promising prevention therapies and find ones that work as soon as possible.

API includes prevention trials of investigational anti-amyloid treatments in cognitively unimpaired persons who based on their age and genetic background are at high imminent risk, including mutation carriers from the world’s largest early-onset autosomal dominant Alzheimer’s disease kindred in Colombia and persons with two copies of the APOE4 gene, the major genetic risk factor for Alzheimer’s in three continents; groundbreaking public-private partnerships and scientific elements; and registries to support interest and enrollment in prevention trials; and other collaborative endeavors to advance prevention research. These and other trials and endeavors to come are intended to help find and support the approval and availability of effective prevention therapies by 2025. 

 

 Pierre Tariot 

Pierre N. Tariot, MD

Titles

Director, Banner Alzheimer’s Institute
Research Professor, University of Arizona College of Medicine

Medical education

University of Rochester School of Medicine in Rochester, New York

Residencies

National Institutes of Health Clinical Center in Bethesda, Maryland
University of Wisconsin School of Medicine and Public Health in Madison, Wisconsin

Fellowship

Intramural Research Program of the National Institute of Mental Health

Board certification

Geriatric Psychiatry
Internal Medicine
Psychiatry

Areas of specialization

  • Internal medicine and geriatric psychiatry

  • Clinical trials

  • Development of experimental therapies for treatment and prevention

  • Evaluation and management of disabling behaviors related to Alzheimer’s disease

  • Patient and family care

Professional highlights

Dr. Tariot has investigated and lectured extensively on multiple aspects of diagnosis, therapy and prevention of Alzheimer’s disease and has published more than 250 papers on these topics. He has served as an author for several studies that have led to Food & Drug Administration (FDA) approval of treatments for Alzheimer’s disease. Dr. Tariot has led efforts to refine how behavioral changes in dementia are measured. He has contributed to large multicenter trials of a range of treatments for these neuropsychiatric features. 

Along with colleagues Jessica Langbaum, PhD, and Eric Reiman, MD, Dr. Tariot leads the Alzheimer’s Prevention Initiative, which is credited with helping launch a new era in Alzheimer’s prevention research. Dr. Tariot also leads the Banner Dementia Care Initiative, a program designed to demonstrate the clinical and cost-effectiveness of standardized care for persons with dementia in a large health care system. He is a member of the American College of Neuropsychopharmacology. 

Dr. Tariot has earned many awards throughout his career, including the:

  • American Geriatrics Society New Investigator Award for Neuroscience

  • Arizona Geriatrics Society Geriatrician of the Year

  • National Institute of Mental Health Geriatric Mental Health Academic Award

  • UCLA Turken Research Award 

 

William Burke

William Burke, MD 

Title

Director, Stead Family Memory Center, Banner Alzheimer’s Institute

Medical education

University of Nebraska Medical Center in Omaha, Nebraska

Internship

University of Nebraska Medical Center, Internal Medicine

Residency

Barnes Hospital and Washington University School of Medicine in St. Louis, Missouri

Post-graduate training

Alzheimer’s Disease Research Center at Washington University School of Medicine
Psychiatric Epidemiology

Board certification

Psychiatry and Geriatric Psychiatry

Area of specialization

Geriatric Psychiatry

Professional highlights

For more than 25 years, Dr. Burke was associated with the University of Nebraska Medical Center, where he served as the Anna O. Stake Professor of Psychiatry, the Vice-Chair for Research and Director of the Psychopharmacology Research Center.

His research focuses on the evaluation of potential new treatments for Alzheimer’s disease, delirium and depression with a particular interest in disease prevention. He has published more than 200 scientific articles, book chapters and abstracts.

Dr. Burke has been repeatedly recognized as a Castle Connolly/U.S. News “Top Doctor” and named in “Best Doctors in America.”

 

 Edward Zamrini

Edward Zamrini, MD

Title

Director, Memory Center, Banner Sun Health Research Institute

Medical education

American University of Beirut in Beirut, Lebanon

Internship

Lutheran Medical Center, Internal Medicine  

Residency

North Shore-Long Island Jewish Health System in New York

Post-graduate training

Medical College of Georgia

Board certification

Neurology

Area of specialization

Cognitive and Geriatric Neurology

Professional highlights

Dr. Zamrini is a neurologist with expertise in cognitive neurology and geriatric neurology. For more than 25 years, he has studied the brain and memory, while also teaching at various universities and participating in prestigious review boards.

 

Jessica Langbaum

Jessica Langbaum, PhD

Titles

Principal Scientist, Banner Alzheimer’s Institute
Associate Director, Alzheimer’s Prevention Initiative

Education

Bachelor’s Degree, Neuroscience and Psychology, Oberlin College in Oberlin, Ohio
Doctoral Degree, Psychiatric Epidemiology, Johns Hopkins University in Baltimore, Maryland

Post-graduate training

Post-Doctoral Research Fellowship (focus on brain imaging and Alzheimer’s disease), Banner Alzheimer’s Institute

Professional highlights

Dr. Langbaum’s doctoral studies focused on cognition and aging in older adults, in particular training interventions to delay or prevent brain and functional decline. 

Since her fellowship, Dr. Langbaum has continued researching the use of brain imaging studies for early evidence of Alzheimer’s. She also has helped design and implement pre-symptomatic Alzheimer’s treatment trials.

Dr. Langbaum has published papers on cognitive training as well as brain imaging and Alzheimer’s disease in leading scientific journals. 

 

Kewei Chen

Kewei Chen, PhD

Titles

Director, Computational Image Analysis, Banner Alzheimer’s Institute
Research Professor, Department of Neurology, University of Arizona College of Medicine in Phoenix, Arizona
Adjunct Faculty, Arizona State University, Department of Mathematics and Statistics in Tempe, Arizona

Education

Bachelor’s and Master’s of Science Degrees, Mathematics, Beijing Normal University in China
Doctoral Degree, Biomathematics, University of California, Los Angeles

Professional highlights

Dr. Chen’s current research focuses on the neuroimaging study of Alzheimer’s disease. He also is pursuing general methodology studies in the neuroimaging field that include PET, MRI and fMRI.

Dr. Chen serves as an academic editor for PLOS ONE journal. He also has authored and co-authored hundreds of papers, some of which focused on the introduction of new methods to process and statistically analyze imaging data.

 

Jan Dougherty

Jan Dougherty, MS, RN, FAAN

Titles

Director, Family and Community Services, Banner Alzheimer’s Institute
Adjunct Faculty, Arizona State University, College of Nursing and Healthcare Innovation in Tempe, Arizona

Education

Bachelor’s of Science in Nursing, Valparaiso University in Valparaiso, Indiana
Master’s of Science, Gerontological Nursing, University of Arizona in Tucson, Arizona

Professional highlights

In addition to her role at Banner Alzheimer’s Institute, Dougherty serves as a preceptor for Doctorate in Nursing Practice students in Adult/Gerontological program at ASU College of Nursing and Healthcare Innovation.

In 2014, Dougherty was named a Piper Fellow by Virginia G. Piper Charitable Trust. During the prestigious fellowship, she studied health care systems that successfully integrate Alzheimer’s disease/dementia care into the primary care model.

Dougherty has been recognized as “Gerontologist of Year” by the Arizona Geriatrics Society and received the “Caring Spirit Award” from the Area Agency on Aging, Region One.

She also has developed online dementia curricula for nursing faculty and community caregivers.